Leerink Partners Initiates Coverage On Edwards Lifesciences with Market Perform Rating, Announces Price Target of $75
Portfolio Pulse from Benzinga Newsdesk
Leerink Partners analyst Mike Kratky has initiated coverage on Edwards Lifesciences (NYSE:EW) with a Market Perform rating and a price target of $75.

October 16, 2023 | 3:46 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Edwards Lifesciences has been given a Market Perform rating by Leerink Partners with a price target of $75.
The news of Leerink Partners initiating coverage on Edwards Lifesciences with a Market Perform rating and a price target of $75 is directly related to the company. This could influence investors' perception of the company and potentially impact its stock price. However, a Market Perform rating suggests that the stock is expected to perform in line with the market, indicating a neutral impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100